REGISTERED
on 10 Aug 2021
Last Applicant/ Owned by
N-3044 Drammen
NO
Serial Number
79303069 filed on 30th Oct 2020
Registration Number
6443720 registered on 10th Aug 2021
Correspondent Address
5 Cheapside
London EC2V 6AA
United Kingdom
Filing Basis
No Filing Basis
Disclaimer
NO DATA
ZOBRIMMUN
Pharmaceutical preparations for the treatment of immune system-related diseases and disorders; antivirals; antibacterial substances for medical purposes; dietary and nutritional supplements for supporting the immune system; antiviral dietary and nutritional supplements; and dietary and nutritional supplements, herbal supplements, vitamin supplements, mineral supplements, vitamin C preparations, vi Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of immune system-related diseases and disorders; antivirals; antibacterial substances for medical purposes; dietary and nutritional supplements for supporting the immune system; antiviral dietary and nutritional supplements; and dietary and nutritional supplements, herbal supplements, vitamin supplements, mineral supplements, vitamin C preparations, vitamin D preparations, all for the treatment of immune system-related diseases and disorders, including viral infections
Mark Details
Serial Number
No 79303069
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Oct 2021 | NOTIFICATION PROCESSED BY IB |
| 28th Sep 2021 | FINAL DISPOSITION PROCESSED |
| 28th Sep 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| 09th Sep 2021 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| 10th Aug 2021 | REGISTERED-PRINCIPAL REGISTER |
| 25th May 2021 | PUBLISHED FOR OPPOSITION |
| 24th May 2021 | NOTIFICATION PROCESSED BY IB |
| 15th May 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 05th May 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 05th May 2021 | NOTICE OF PUBLICATION |